Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
Open Access
- 1 January 2020
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 53 (7) , e9646
Abstract
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome in which patients have symptoms and signs of HF with normal or near-normal left ventricular ejection fraction (LVEF ≥50%). Roughly half of all patients with HF worldwide have an LVEF ≥50% and nearly half have an LVEF <50%. Thanks to the increased scientific attention about the condition and improved characterization and diagnostic tools, the incidence of HF with reduced ejection fraction (HFrEF) dropped while that of HFpEF has increased by 45%. HFpEF has no single guideline for diagnosis or treatment, the patient population is heterogeneously and inconsistently described, and longitudinal studies are lacking. To better understand and overcome the disease, in this review, we updated the latest knowledge of HFpEF pathophysiology, introduced the existing promising diagnostic methods and treatments, and summarized its prognosis by reviewing the most recent cohort studies.Keywords
This publication has 73 references indexed in Scilit:
- Decreased Cardiac Functional Reserve in Heart Failure With Preserved Systolic FunctionJournal of Cardiac Failure, 2011
- Chronotropic IncompetenceCirculation, 2011
- Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatmentEuropean Heart Journal, 2010
- Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection FractionCirculation: Heart Failure, 2010
- Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection FractionJACC, 2010
- Impaired Heart Rate Recovery and Chronotropic Incompetence in Patients With Heart Failure With Preserved Ejection FractionCirculation: Heart Failure, 2010
- A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effects of Valsartan on Exercise Time in Patients with Symptomatic Heart Failure with Preserved Ejection FractionEuropean Journal of Heart Failure, 2009
- Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialCirculation, 2008
- Death in Heart FailureCirculation: Heart Failure, 2008
- Effects of Digoxin on Morbidity and Mortality in Diastolic Heart FailureCirculation, 2006